
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
VJHemOnc Podcast
Implications of Refining Classifications and Treatment Approaches for MDS Patients
Exploring the implications of refining classifications for patients with myelodysplastic syndromes (MDS) on treatment decisions, including the challenges in initiating therapy for asymptomatic patients and the potential benefits of immune-based therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.